Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 38, Issue 9, Pages 4695-4708
Publisher
Springer Science and Business Media LLC
Online
2021-07-27
DOI
10.1007/s12325-021-01852-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients
- (2021) François Schiele et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany
- (2021) Ingo Ahrens et al. ADVANCES IN THERAPY
- Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
- (2020) Ali Allahyari et al. EUROPEAN HEART JOURNAL
- Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction
- (2020) Baris Gencer et al. JAMA Cardiology
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review
- (2018) Dasha Cherepanov et al. CURRENT MEDICAL RESEARCH AND OPINION
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific Literature
- (2016) Susanna M. Wallerstedt et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Cardiovascular disease in Europe: epidemiological update 2016
- (2016) Nick Townsend et al. EUROPEAN HEART JOURNAL
- Registers of the Swedish total population and their use in medical research
- (2016) Jonas F. Ludvigsson et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- An International Model to Predict Recurrent Cardiovascular Disease
- (2012) Peter W.F. Wilson et al. AMERICAN JOURNAL OF MEDICINE
- External review and validation of the Swedish national inpatient register
- (2011) Jonas F Ludvigsson et al. BMC PUBLIC HEALTH
- High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries
- (2011) Gregory A Roth et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started